Bantas, Acas M.
HRN: 04-41-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2024
02/09/2024
IV
500mg
Q8
Abdominal Mass
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes